Gemifloxacin mesylate News Headlines

• Pivotal Submission Data Shows Tasigna(R) Achieved Impressive Response Rates In Chronic Myeloid Leukemia Patients No Longer Helped By Gleevec(R)
  MedicalNewsToday - Tue, 26 Dec 2006 08:00 EST
  
• Gleevec(R) Demonstrates Highest Five-Year Overall Survival Rate In History Of Treatment For Patients With Chronic Myeloid Leukemia
  MedicalNewsToday - Thu, 07 Dec 2006 08:00 EST
  
• Interim Analysis Of New Study Suggests Boosted INVIRASE(R) May Achieve Similar Levels Of HIV Suppression To Boosted Lopinavir
  MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST
  
• Ruboxistaurin Reduced Vision Loss In Patients With Moderate To Severe Non-Proliferative Diabetic Retinopathy In A New Study
  MedicalNewsToday - Tue, 14 Nov 2006 08:00 EST
  
• Lilly Announces FDA Requirement Of Additional Clinical Trial Before Ruboxistaurin Could Be Approved For Treatment Of Diabetic Retinopathy
  MedicalNewsToday - Sat, 30 Sep 2006 07:00 EST
  
• Can Gleevec Help Patients With Rheumatoid Arthritis?
  MedicalNewsToday - Fri, 15 Sep 2006 09:00 EST
  
• Approvable Letter Issued By FDA For Arxxant™ (ruboxistaurin Mesylate) For Diabetic Retinopathy
  MedicalNewsToday - Sun, 20 Aug 2006 11:00 EST
  
• Lilly And Alcon Sign Marketing Collaboration For Potentially The First Oral Medication For Diabetic Retinopathy
  MedicalNewsToday - Sun, 23 Jul 2006 06:00 EST
  
• Novartis Completes Submissions In US And Europe For Glivec As Treatment For Four Rare Types Of Cancer
  MedicalNewsToday - Mon, 17 Apr 2006 06:00 EST
  
• Hepatitis B - Metabasis Comments On Positive 48 Week HBV Data From Pradefovir Mesylate Phase 2
  MedicalNewsToday - Thu, 16 Mar 2006 11:00 EST
  
• Kidney Cancer Patients Unlikely To Respond To Potential Treatment Drug
  MedicalNewsToday - Sat, 31 Dec 2005 04:00 EST
  
• Lilly Will Submit Ruboxistaurin Mesylate to FDA for Treatment of Diabetic Retinopathy in 2005
  MedicalNewsToday - Sun, 07 Aug 2005 08:00 EST
  
• Patients treated with boosted Invirase, a potent anti-HIV treatment, do not develop resistance
  MedicalNewsToday - Wed, 27 Jul 2005 11:00 EST
  
• Europe approves new Invirase 500 mg tablet for the treatment of HIV
  MedicalNewsToday - Sat, 28 May 2005 06:00 EST
  
• Europe approves new Invirase 500 mg tablet for the treatment of HIV
  MedicalNewsToday - Fri, 27 May 2005 07:00 EST